Bioprocessing engineering is a critical part of biotechnology which is widely used to produce clinically important, high-value therapeutics such as monoclonal antibodies, recombinant proteins, viruses, plasmid DNA and vaccines in large scale quantities
The bioprocessing community is constantly in need of new technologies to address challenges in GMP compliant, large-scale production from and range of bioreactor formats and varied downstream unit operations.
Within Bioprocessing, there are a number of challenges linked to the robust, reproducible, scalable and cost effective production of each therapeutic class. In addition, through the applications of the core principles the industry continues to strive develop cost effective medicines by streamlining production methodologies whilst maintaining/improving the product profile and importantly, the patient safety profile of these key biotherapeutic classes. In particular, the need for scalable cost-effective manufacturing is a key requirement for the field.
Commercially relevant bioprocesses will: